Panacea Biotec Limited (BOM:531349)
India · Delayed Price · Currency is INR 410.40
-3.65 (-0.88%)
At close: Aug 21, 2026
Panacea Biotec Market Cap
Panacea Biotec has a market cap or net worth of 25.18 billion as of August 21, 2026. Its market cap has decreased by -0.09% in one year.
Market Cap
25.18B
Enterprise Value
24.61B
Revenue
6.73B
Ranking
n/a
PE Ratio
n/a
Stock Price
410.40
ChartMarket Cap Chart
Since April 1, 2002, Panacea Biotec's market cap has increased from 21.08B to 25.18B, an increase of 19.48%. That is a compound annual growth rate of 0.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 25.18B | 9.25% |
| Dec 31, 2025 | 23.05B | -10.11% |
| Dec 31, 2024 | 25.64B | 149.32% |
| Dec 29, 2023 | 10.28B | 18.20% |
| Dec 30, 2022 | 8.70B | -28.49% |
| Dec 31, 2021 | 12.17B | -17.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aarti Drugs | 38.12B |
| Hester Biosciences | 20.30B |
| Titan Biotech | 16.50B |
| Zenotech Laboratories | 2.82B |
| CCME Global | 2.32B |
| Bharat Immunologicals & Biologicals Corporation | 682.24M |
| Transgene Biotek | 210.64M |
| Hindustan Bio Sciences | 68.78M |